NASDAQ: HCM $5 Billion Mid-Cap. Health Care Sector. Drug Manufacturers Industry. 5 Year Return 153%. 1 Year Return 47%. 2021 YTD Return 0%. Since Earnings 22%.
The 52 Week Low is $14.74 set on Wed, Mar 18, 2020.
The 52 Week High is $36.91 set on Fri, Jan 8, 2021.
The All-Time High is $42.25 set on Tue, Jan 2, 2018.
Earnings Per Share
Price To Earnings Ratio
Dividend Yield
Dividend Rate
Ex-Dividend Date
Dividend Payment Date
Dividend Frequency
Dividend History
Hutchison China MediTech Limited - American Depositary Shares trades on the NASDAQ. HCM's market cap is 5.0 Billion.
Hutchison China Meditech is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Its reportable segments include the innovation platform and commercial platform. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The commercial platform includes a prescription drugs business and a consumer health business for over-the-counter drugs.
For Starters
Track your portfolio and more.
